Abstract
Background: The CHA2DS2-VASC score is a well-validated clinical risk tool for assessment of thromboembolic risk in patients with non–valvular atrial fibrillation (AF). Imaging abnormalities on transoesophageal echocardiography (TOE) are associated with thromboembolic risk. We aim to evaluate an association between TOE abnormalities and transthoracic echocardiogram (TTE) parameters that would help further stratify thromboembolic risk.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
